Champions Oncology expands integrated radiopharmaceutical development with in-house SPECT/CT imaging
Champions Oncology said new molecular imaging capabilities link longitudinal radiopharmaceutical uptake to biodistribution, efficacy and clinically annotated PDX tumor biology within a single, U.S.-based workflow.
New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribution, efficacy and clinically annotated PDX tumor biology in a single, U.S.-based workflowHACKENSACK, NJ / / September 1, 2026 / Champions Oncology, Inc., a leading provider of transla…